In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units
Alyssa Golden, Heather J. Adam, Melanie Baxter, Andrew Walkty, Philippe Lagacé‐Wiens, James A. Karlowsky, George G. Zhanel
Topics & Concepts
Stenotrophomonas maltophiliaAcinetobacter baumanniiMicrobiologyBacilliCephalosporinPseudomonas aeruginosaBroth microdilutionBiologySiderophoreAcinetobacterCarbapenemStenotrophomonasGram-negative bacterial infectionsIntensive careAntibioticsPseudomonasMinimum inhibitory concentrationMedicineBacteriaIntensive care medicineGeneticsAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyNosocomial Infections in ICU